Discovery Laboratories, Inc. (DSCO): Are Hedge Funds Right About This Stock?
Is Discovery Laboratories, Inc. (NASDAQ:DSCO) a healthy stock for your portfolio? Investors who are in the know are getting less optimistic.
Complete Genomics Inc (GNOM)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.05 | 100,000 | Large Shareholder | 201,043 | 2011-12-14 | Filing | |
| $3.05 | 100,000 | Large Shareholder, Director | 201,043 | 2011-12-14 | Filing | |
| $7.94 | 10,000 | Officer | 10,000 | 2011-08-08 | Filing | |
| $12.50 | 10,623 | Large Shareholder | 2,505,489 | 2011-05-26 | Filing | |
| $9.00 | 111,111 | Large Shareholder | 667,068 | 2010-11-16 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.51 | 4,500 | Large Shareholder | 27,859 | 2012-07-13 | Filing | |
| $2.51 | 474,800 | Large Shareholder | 2,922,141 | 2012-07-13 | Filing | |
| $2.85 | 2,076 | Large Shareholder | 32,359 | 2012-07-12 | Filing | |
| $2.85 | 218,624 | Large Shareholder | 3,396,941 | 2012-07-12 | Filing | |
| $2.90 | 4,792 | Large Shareholder | 34,435 | 2012-07-11 | Filing |
News See All
This Metric Says You Are Smart to Buy Vanda Pharmaceuticals Inc. (VNDA)
In the 21st century investor’s toolkit, there are many indicators shareholders can use to watch the equity markets. Two of the most underrated are hedge fund and insider trading interest.
Is Complete Genomics, Inc. (GNOM) Going to Reward These Hedge Funds?
Complete Genomics, Inc. (NASDAQ:GNOM) was in 9 hedge funds' portfolio at the end of the fourth quarter of 2012.